Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0537-1482 in Heart Failure
NCT07218627Phase 1Recruiting
- Sponsor
- Novo Nordisk
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of NNC0537-1482 in heart failure (HF) (7 arms), sponsored by Novo Nordisk. Primary endpoint: Number of treatment emergent adverse events. Started Oct 2025; status: recruiting.
02
Drugs
NNC0537-1482
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07218627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218627.